SCHEMBL4464429

SCHEMBL4464429

Cc1nc(N2CCOCC2)ccc1-c1ccc(NC(=O)Nc2ccccc2)c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.52
MTOR P42345 8/20 0.52
PIK3R1 P27986 6/20 0.52
PIK3CD O00329 1/20 0.52
PIK3CB P42338 1/20 0.52
KDM4E B2RXH2 6/20 0.49
HIF1A Q16665 3/20 0.49
PIK3CG P48736 2/20 0.49
MEN1 O00255 1/20 0.48
USP2 O75604 1/20 0.48
KMT2A Q03164 1/20 0.48
KDR P35968 1/20 0.47
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
CLK2 P49760 1/20 0.45
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
CSNK2A1 P68400 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067699 0.90 CNR1 (0.47) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL7069390 0.87 EPHX2 (0.49) KDM4EALDH1A1MAPTCLK2GSK3A
SCHEMBL7189256 0.87 RAF1 (0.54) KDM4ECLK2GSK3AGSK3BCSNK2A1
SCHEMBL7064948 0.86 KDM4E (0.45) PIK3CAMTORPIK3CDPIK3CBKDM4E
SCHEMBL4456006 0.84 MAPK1 (0.42) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL7070212 0.82 MAPK14 (0.49) PIK3CAPIK3CDPIK3CBKDM4EMEN1
SCHEMBL6257285 0.82 MTOR (0.41) PIK3CAMTORPIK3CDPIK3CBKDM4E
SCHEMBL5462710 0.81 PIK3CA (0.40) PIK3CAMTORPIK3R1PIK3CDPIK3CB
SCHEMBL28747223 0.81 CLK2 (0.49) KDM4EMEN1USP2KMT2AKDR
SCHEMBL27559838 0.80 MAPK14 (0.54) KDM4EKMT2AALDH1A1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2116245-A2 EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders Boehringer Ingelheim International GmbH (DE) 2009-11-11 EP disclosed